These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33457288)

  • 1. Nephron-sparing surgery for the management of upper tract urothelial carcinoma: an outline of surgical technique and review of outcomes.
    Nandurkar R; Basto M; Sengupta S
    Transl Androl Urol; 2020 Dec; 9(6):3160-3167. PubMed ID: 33457288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review.
    Cutress ML; Stewart GD; Zakikhani P; Phipps S; Thomas BG; Tolley DA
    BJU Int; 2012 Sep; 110(5):614-28. PubMed ID: 22471401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel.
    Seisen T; Peyronnet B; Dominguez-Escrig JL; Bruins HM; Yuan CY; Babjuk M; Böhle A; Burger M; Compérat EM; Cowan NC; Kaasinen E; Palou J; van Rhijn BW; Sylvester RJ; Zigeuner R; Shariat SF; Rouprêt M
    Eur Urol; 2016 Dec; 70(6):1052-1068. PubMed ID: 27477528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and kidney-sparing treatments for upper tract urothelial carcinoma: state of the art.
    Territo A; Foerster B; Shariat SF; Rouprêt M; Gaya JM; Palou J; Breda A
    Minerva Urol Nefrol; 2018 Jun; 70(3):242-251. PubMed ID: 29392926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephron-Sparing Approaches in Upper Tract Urothelial Carcinoma: Current and Future Strategies.
    Ham WS; Park JS; Jang WS; Kim J
    Biomedicines; 2022 Sep; 10(9):. PubMed ID: 36140325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephron-sparing approaches in the management of upper tract urothelial carcinoma: indications and clinical outcomes.
    Ko YH
    Transl Cancer Res; 2020 Oct; 9(10):6589-6595. PubMed ID: 35117269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience.
    Cutress ML; Stewart GD; Wells-Cole S; Phipps S; Thomas BG; Tolley DA
    BJU Int; 2012 Dec; 110(11):1608-17. PubMed ID: 22564677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: a 15-year comprehensive review of 160 consecutive patients.
    Grasso M; Fishman AI; Cohen J; Alexander B
    BJU Int; 2012 Dec; 110(11):1618-26. PubMed ID: 22458598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk-adapted strategy for the kidney-sparing management of upper tract tumours.
    Seisen T; Colin P; Rouprêt M
    Nat Rev Urol; 2015 Mar; 12(3):155-66. PubMed ID: 25708579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney-sparing surgery for upper tract urothelial cancer.
    Lucca I; Klatte T; Rouprêt M; Shariat SF
    Curr Opin Urol; 2015 Mar; 25(2):100-4. PubMed ID: 25581542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney sparing surgery for upper-tract urothelial carcinoma.
    Raman JD
    Minerva Urol Nefrol; 2016 Aug; 68(4):359-71. PubMed ID: 27058053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney autotransplantation after nephrectomy and work bench surgery as an ultimate approach to nephron-sparing surgery.
    Janssen MWW; Linxweiler J; Philipps I; Bütow Z; Siemer S; Stöckle M; Ohlmann CH
    World J Surg Oncol; 2018 Feb; 16(1):35. PubMed ID: 29463251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced chronic kidney disease; A comparison between nephroureterectomy and nephron-sparing surgery for upper tract urothelial carcinoma.
    Dudinec JV; Ortiz-Melo DI; Lipkin ME; Abern MR; Shah AM; Inman BA
    Urol Oncol; 2023 Jun; 41(6):295.e19-295.e25. PubMed ID: 36526526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upper tract urothelial carcinoma: Paradigm shift towards nephron sparing management.
    Fiuk JV; Schwartz BF
    World J Nephrol; 2016 Mar; 5(2):158-65. PubMed ID: 26981440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Techniques and Outcomes of Robot-assisted Nephro-ureterectomy for Upper Tract Urothelial Carcinoma.
    Pathak RA; Hemal AK
    Eur Urol Focus; 2018 Sep; 4(5):657-661. PubMed ID: 30146238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review and meta-analysis of oncological and renal function outcomes obtained after segmental ureterectomy versus radical nephroureterectomy for upper tract urothelial carcinoma.
    Fang D; Seisen T; Yang K; Liu P; Fan X; Singla N; Xiong G; Zhang L; Li X; Zhou L
    Eur J Surg Oncol; 2016 Nov; 42(11):1625-1635. PubMed ID: 27612412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncologic results of nephron sparing endoscopic approach for upper tract low grade transitional cell carcinoma in comparison to nephroureterectomy - a case control study.
    Hoffman A; Yossepowitch O; Erlich Y; Holland R; Lifshitz D
    BMC Urol; 2014 Dec; 14():97. PubMed ID: 25468319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organ-sparing procedures in GU cancer: part 3-organ-sparing procedures in urothelial cancer of upper tract, bladder and urethra.
    Khalil MI; Alliston JT; Bauer-Erickson JJ; Davis R; Bissada NK; Kamel MH
    Int Urol Nephrol; 2019 Nov; 51(11):1903-1911. PubMed ID: 31352580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ureteroscopic management of upper tract urothelial carcinoma (UTUC) in patients with Lynch Syndrome (hereditary nonpolyposis colorectal cancer syndrome).
    Hubosky SG; Boman BM; Charles S; Bibbo M; Bagley DH
    BJU Int; 2013 Oct; 112(6):813-9. PubMed ID: 23452166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduce bladder cancer recurrence in patients treated for upper urinary tract urothelial carcinoma: The REBACARE-trial.
    van Doeveren T; van Leeuwen PJ; Aben KKH; van der Aa M; Barendrecht M; Boevé ER; Cornel EB; van der Heijden AG; Hendricksen K; Hirdes W; Kooistra A; Kroon B; Leliveld AM; Meijer RP; van Melick H; Merks B; de Reijke TM; de Vries P; Wymenga LFA; Wijsman B; Boormans JL
    Contemp Clin Trials Commun; 2018 Mar; 9():121-129. PubMed ID: 29696234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.